The effect of Exercplay and Thoracic lymphatic pump technique on functional capacity and inflammatory parameters in children with bronchial asthma.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 114
- Locations
- 1
- Primary Endpoint
- 1. Sputum eosinophil count
Study Overview
Brief Summary
Bronchial asthma (BA) is a chronic inflammatory respiratory condition characterized by bronchial hyperresponsiveness and airflow obstruction, often leading to symptoms like wheezing, shortness of breath, chest tightness, and cough. It not only affects respiratory health but can also result in reduced functional capacity, exertional dyspnea, fatigue, and activity limitations, impacting the quality of life. In children, asthma may reduce physical activity levels, with 5.5 million affected worldwide, constituting 7.5% of all children. Three key pathophysiological processes contribute to BA: bronchial inflammation, allergies, and bronchial hyperreactivity. These processes involve inflammatory cells, allergens, and excessive bronchoconstrictor responses. Current physiotherapy treatments aim to educate patients on asthma management and improve lung elasticity while addressing musculoskeletal dysfunctions. The thoracic lymphatic pump technique is a noninvasive approach for children with asthma, enhancing deep breathing and ventilation functions. Exercplay combines outdoor exercise and play to promote physical activity among children with controlled asthma. Physical fitness is associated with improved quality of life and reduced morbidity. These techniques have been used in various pulmonary conditions demonstrating promising effects on functional improvement and quality of life.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 7.00 Year(s) to 12.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Children with mild to moderate Bronchial asthma assessed using pulmonary function test Asthmatic children with presence of sputum Participants will be recruited with reference to asthma diagnosis criterions of Global Initiative for Asthma including a history of variable respiratory symptoms and confirmed variable expiratory airflow limitation Children with well-controlled asthma, with no changes in asthma medication for less than 1 month and children who use inhalers bronchodilators will be included in the study.
Exclusion Criteria
- •Children with severe and unstable asthma Subjects with poor cognition and perception & an inability to understand instructions necessary for assessment and treatment.
- •Participants with other cardiopulmonary, neurological and musculoskeletal disorders.
- •Exacerbation of asthma symptoms that required the use of systemic corticosteroids in the previous 4 week or during the study period.
- •Children with a history of thoracic surgery.
- •Children with Chest and Spinal deformities Red flag signs such as benign and malignant tumour.
Outcomes
Primary Outcomes
1. Sputum eosinophil count
Time Frame: 5 YEARS
2. Fractional exhaled nitric oxide (FeNO)
Time Frame: 5 YEARS
Secondary Outcomes
- Six-minute walk test(Pediatric Asthma Quality of Life Questionnaire)
Investigators
Preethi Gokulan
Saveetha college of physiotherapy, Saveetha University
